Menu

The HHMI Bump

A new study shows a slight citation benefit to authors recently awarded investigator status from the Howard Hughes Medical Institute.

Jan 28, 2014
Bob Grant

WIKIMEDIA, DVORTYGIRLScientific papers published just prior to their authors being awarded a coveted investigator position at the Howard Hughes Medical Institute (HHMI) are cited 12 percent more than expected, according to new research. The citation bump was more pronounced for papers published in new areas of research or in lower-profile journals. The study, published in this month’s issue of Management Science, compared more than 3,600 life science papers written by 424 HHMI investigators to an equal number of papers written by researchers who had not received the honor. “We found that there was an effect of status,” MIT economist Pierre Azoulay, study coauthor, said in a statement.

Azoulay and his collaborators tracked changes in the citation rates of papers before and after one or more of their authors were named HHMI investigators. They found that citations jumped for some of the papers just after their authors joined the HHMI fold.

“You couldn’t tell them [the pairs of papers] apart in terms of citation trajectories, up until the time of the prize,” Azoulay said.

But the effect was more pronounced in some instances. The citation bump was nearly twice as great for papers published in lower-profile journals, and younger researcher/authors, with less robust reputations prior to their HHMI appointments were more likely to experience the benefits of the award. “The effect was much more pronounced when there was more reason to be uncertain about the quality of the science or the scientist before the prize,” Azoulay added.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.